Montara Therapeutics
PrivateLast Round
Grant
Jun 2, 2026
Total Funding Raised
$32.3M
Company Overview
Montara Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in June 2026.
Montara Therapeutics is a biotechnology company that develops brain-selective therapies for central nervous system diseases using its proprietary BrainOnly™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Montara Therapeutics Comparables
Compare Montara Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Violet Therapeutics | 72% | |
| AbbVie | 71% | |
| Acurex Biosciences | 68% |
For institutional investors. Book with your work email.
Montara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Grant | May 21, 2025 | ||||
| Seed | Mar 13, 2025 | ||||
| Seed | Jul 30, 2024 | ||||
| Seed | Jan 5, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Montara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| Dolby Family Ventures | Seed |
| SV Health Investors | Seed |
| Two Bear Capital | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Partnering with the TSC Alliance to advance lead program.
- Dec 8, 2025
Initial data on MT1110-everolimus combination presented at AES Annual Meeting.
For institutional investors. Book with your work email.
Montara Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Montara Therapeutics's valuation, stock price, and market status.
Is Montara Therapeutics a public or private company?
Montara Therapeutics is a private company.
What is the current stock price of Montara Therapeutics?
Montara Therapeutics is a private company, so its shares have no public market price. Caplight tracks Montara Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Montara Therapeutics worth (valuation)?
Valuation information for Montara Therapeutics is not publicly available.
Can I buy Montara Therapeutics stock?
Montara Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Montara Therapeutics's last funding round?
Montara Therapeutics's most recent funding round was Grant on June 2, 2026.
Who are the main investors in Montara Therapeutics?
Key investors in Montara Therapeutics include SV Health Investors, Two Bear Capital.
Will Montara Therapeutics IPO soon?
No public IPO plans have been announced for Montara Therapeutics.
How can I track Montara Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Montara Therapeutics's shares on secondary markets.